Chemkart India Ltd
Incorporated in 2020, Chemkart India Limited, based in Mumbai, is a B2B nutraceutical ingredient distributor and processor.[1]
- Market Cap ₹ 222 Cr.
- Current Price ₹ 183
- High / Low ₹ 262 / 87.0
- Stock P/E 11.3
- Book Value ₹ 107
- Dividend Yield 0.00 %
- ROCE 27.7 %
- ROE 21.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 37.8%
- Promoter holding has increased by 1.35% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Other Food Products
Part of BSE SME IPO
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 87 | 131 | 132 | 203 | 215 | |
| 80 | 120 | 111 | 171 | 187 | |
| Operating Profit | 7 | 11 | 21 | 33 | 28 |
| OPM % | 8% | 8% | 16% | 16% | 13% |
| 0 | 0 | 1 | 2 | 1 | |
| Interest | 0 | 1 | 1 | 2 | 1 |
| Depreciation | 0 | 0 | 0 | 1 | 0 |
| Profit before tax | 7 | 11 | 20 | 33 | 27 |
| Tax % | 25% | 27% | 27% | 26% | 27% |
| 5 | 8 | 15 | 24 | 20 | |
| EPS in Rs | 40.38 | 56.45 | 107.00 | 25.55 | 16.25 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 42% |
| 3 Years: | 38% |
| Last Year: | 21% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 10 | 12 |
| Reserves | 5 | 13 | 28 | 44 | 118 |
| 6 | 11 | 13 | 17 | 5 | |
| 12 | 12 | 12 | 16 | 22 | |
| Total Liabilities | 25 | 37 | 54 | 86 | 157 |
| 1 | 6 | 5 | 9 | 8 | |
| CWIP | -0 | -0 | -0 | 0 | 5 |
| Investments | -0 | -0 | -0 | -0 | -0 |
| 24 | 32 | 48 | 77 | 144 | |
| Total Assets | 25 | 37 | 54 | 86 | 157 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -6 | 0 | -0 | 4 | -3 | |
| -1 | -5 | -0 | -4 | -5 | |
| 7 | 5 | 0 | 3 | 43 | |
| Net Cash Flow | -0 | 0 | -0 | 3 | 36 |
| Free Cash Flow | -7 | -5 | -0 | -0 | -8 |
| CFO/OP | -85% | 34% | 24% | 31% | 18% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 80 | 62 | 87 | 82 | 85 |
| Inventory Days | 9 | 25 | 27 | 50 | 71 |
| Days Payable | 41 | 34 | 33 | 23 | 38 |
| Cash Conversion Cycle | 49 | 53 | 81 | 109 | 119 |
| Working Capital Days | 28 | 25 | 66 | 75 | 106 |
| ROCE % | 58% | 63% | 62% | 28% |
Insights
In beta| Mar 2024 | Sep 2025 | |
|---|---|---|
| Amino Acids Revenue Share % ・Standalone data |
|
|
| Sports Nutrition Revenue Share % ・Standalone data |
||
| Blending Capacity MT/Day |
||
| Customer Count Count |
||
| Grinding Capacity MT/Day |
||
| Number of Ingredients Count |
||
| Warehouse Capacity sq.ft |
||
Extracted by Screener AI
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 9 Jul
-
Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
8 Jul - Promoter group member acquired 1,200 shares on 6 July 2026.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 6 Jul
-
Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
3 Jul - Promoter Shailesh Mehta acquired 1,800 shares on 1 July 2026.
-
Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
3 Jul - Promoter Shailesh Mehta acquired 1,800 shares on 1 July 2026.
Annual reports
No data available.
Business Segment[1]
a) Trading Business:(97% of H1FY25 revenue)[2]
The company sources a wide range of nutraceutical ingredients—such as amino acids, vitamins, herbal extracts, and proteins—mainly through imports, and supplies them to B2B clients for manufacturing finished supplements.